Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp

<< Previous

Bullboard Posts

Next >>

Post by subaru1ion Mar 27, 2024 4:23pm

110 Views

Post# 35956470

OH, OH!!!!!!!!!!! OH F!!! 'undervalued', '18 million cash'

BUT NO MENTION OF ANY STOCK BUY BACK! The LOGIC just slapped me in the face harder than a magnum goose load when management is saying in the same breath, undervalued, strong cash position and then leaves it at that.

MAJOR ANNOUNCMENT PENDING DEA RESCHEDULING FOLKS.

Because any CEO worth his salt knowing the company is undervaled and has strong cash position would take advantage of that.

<< Previous

Bullboard Posts

Next >>

3 Canadian companies getting a boost during Stanley Cup Playoffs